Your browser does not support the video tag.
Skip to content
home button
  • Resources
    • By Topic
      • Access to Clinical Trials
      • Artificial Intelligence
      • Clinical Trials Landscape
      • Data Collecting + Reporting
      • Ensuring Quality
      • Innovative Trials
      • Patient Engagement
      • Recruitment
      • Regulatory Submissions + Approvals
      • Safety
      • Site Planning
    • By Trial Stage
      • Study Design
        • Innovative Trials
        • Patient Group Engagement
        • Recruitment
      • Study Operations
        • Data Collecting
        • Regulatory Submissions + Approvals
        • Site Planning
  • Case Studies
  • About CTTI
  • Newsroom
  • Membership
  • Annual Report
connect with us
Signup for our Newsletter
  • About CTTI
  • Newsroom
  • Membership
  • Annual Report
Search

CTTI

Clinical Trials Transformation Initiative

Study Design

Executive Summary: CTTI Recommendations for Efficient and Effective Clinical Trial Recruitment Planning

Posted on August 4, 2021February 10, 2025 by Hannah Faulkner

Executive Summary: CTTI Recommendations for Efficient and Effective Clinical Trial Recruitment Planning

Posted in Ensuring Quality, Recommendations, Recruitment, Recruitment, Recruitment, Related: Recruitment, Study Design, Study Operations

Advancing the Landscape: Increasing Diversity in Clinical Trials

Posted on August 4, 2021February 21, 2025 by Hannah Faulkner

Advancing the Landscape: Increasing Diversity in Clinical Trials

Posted in Access to Clinical Trials, Diversity, Diversity in Clinical Trials, Patient Engagement, Related: Diversity, Resources, Study Design

Best Practices for Designing High-Quality, Diverse COVID-19 Trials

Posted on July 9, 2021February 21, 2025 by Hannah Faulkner

Best Practices for Designing High-Quality, Diverse COVID-19 Trials

Posted in Access to Clinical Trials, COVID 19, COVID-19, Ensuring Quality, Innovative Trials, Regulatory Submissions + Approvals, Related: COVID 19, Resources, Study Design, Study Operations

Best Practices for Conducting Trials during the COVID-19 Pandemic

Posted on July 9, 2021February 21, 2025 by Hannah Faulkner

Best Practices for Conducting Trials during the COVID-19 Pandemic

Posted in Access to Clinical Trials, COVID 19, COVID-19, Ensuring Quality, Innovative Trials, Regulatory Submissions + Approvals, Related: COVID 19, Resources, Study Design, Study Operations

Informing the Renovations to the ICH E6 GCP Guideline for Good Clinical Practice Executive Summary

Posted on July 9, 2021February 5, 2025 by Hannah Faulkner

Informing the Renovations to the ICH E6 GCP Guideline for GCP Executive Summary

Posted in Ensuring Quality, Informing ICH E6 Renovation, Informing ICH E6 Renovation, Related: Informing ICH E6 Renovation, Resources, Study Design

Digital Health Trials: Recommendations for Selecting and Testing a Digital Health Technology

Posted on July 8, 2021February 11, 2025 by Hannah Faulkner

Digital Health Trials: Recommendations for Selecting and Testing a Digital Health Technology

Posted in Digital Health Technologies, Innovative Trials, Recommendations, Selecting and Testing Digital Health Technology, Study Design

Digital Health Trials: Recommendations for Managing Data

Posted on July 8, 2021February 6, 2025 by Hannah Faulkner

Digital Health Trials: Recommendations for Managing Data

Posted in Data Collecting and Reporting, Innovative Trials, Managing Data, Managing Data, Recommendations, Study Design, Study Operations

Digital Health Trials: Recommendations for Interacting with Regulators

Posted on July 8, 2021February 5, 2025 by Hannah Faulkner

Digital Health Trials: Recommendations for Interacting with Regulators

Posted in Innovative Trials, Interacting with Regulators, Interacting with Regulators, Key Materials, Recommendations, Regulatory Submissions + Approvals, Study Design

Prioritization Tool for Sponsors and Patient Groups

Posted on June 30, 2021February 7, 2025 by Hannah Faulkner

Prioritization Tool for Sponsors and Patient Groups

Posted in Patient Engagement, Patient Group Engagement, Patient Group Engagement, Patient-centered, Resources, Study Design

Pregnancy Testing Outcomes Predictor for Clinical Trials

Posted on June 30, 2021February 7, 2025 by Hannah Faulkner

Pregnancy Testing Outcomes Predictor for Clinical Trials

Posted in Ensuring Quality, Planning for Pregnancy Testing, Pregnancy Testing, Resources, Study Design

Posts navigation

← Older posts
Newer posts →
 

DISCLAIMER: CTTI encourages the use of all materials listed on this site in the pursuit of improving the clinical trials enterprise. Our recommendations, tools, meeting summaries, and more are available to the public for free. We do ask that you acknowledge the source whenever using or referencing CTTI materials. Read our Citation Policy. 

  • About
  • Newsroom
  • Membership
  • Case Studies
  • Contact Us
  • Access to Clinical Trials
  • Artificial Intelligence
  • Clinical Trials Landscape
  • Data Collecting + Reporting
  • Ensuring Quality
  • Innovative Trials
  • Informed Consent
  • Patient Group Engagement
  • Real-World Data
  • Recruitment
  • Regulatory Submissions + Approvals
  • Safety + Protection
  • Site Planning
Sign up for our Newsletter
Log in

© Clinical Trials Transformation Initiative © 2026

terms of use

privacy statement

WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.